Solvent and Copper Ion-Induced Synthesis of Pyridyl-Pyrazole-3-One Derivatives: Crystal Structure, Cytotoxicity

Area of Science:

• * Organic Synthesis and Medicinal Chemistry
• * Coordination Chemistry
• * Cancer Biology

Background:

• * Pyrazole derivatives are recognized for their diverse biological activities, including potential anticancer properties.
• * Development of novel compounds with selective cytotoxicity against cancer cells is a critical area in oncology research.
• * Metal complexes are increasingly explored for their therapeutic potential in cancer treatment.

Purpose of the Study:

• * To synthesize and characterize novel pyrazole-based compounds and their metal complexes.
• * To evaluate the in vitro antitumor activity of these novel compounds against a panel of human cancer cell lines.
• * To assess the selective cytotoxicity of the synthesized compounds towards cancer cells compared to normal liver cells.

Main Methods:

• * Synthesis of five novel compounds (1-5) including pyrazole derivatives and a copper complex.
• * Characterization using elemental analysis, IR, NMR (¹H, ¹³C), ESI-MS, and X-ray single-crystal diffraction.
• * In vitro antitumor activity screening using the methylthiazolyl tetrazolium (MTT) assay on BEL-7404, HepG2, NCI-H460, T-24, and A549 cell lines.

Main Results:

• * Compounds 1 and 2 exhibited weak growth inhibition against HepG2 cells.
• * Compound 4 (a copper complex) showed significant cytotoxicity against HepG2 and A549 cell lines with IC50 values of 10.66 μM and 28.09 μM, respectively.
• * Compounds 1-5 demonstrated no significant cytotoxicity against the normal human liver cell line HL-7702, indicating selective anticancer effects.

Conclusions:

• * Novel pyrazole compounds and a copper complex were successfully synthesized and characterized.
• * Compound 4 displays promising selective antitumor activity against specific cancer cell lines.
• * Further investigation into compound 4 as a potential lead for anticancer drug development is warranted.